Talhia Tuck
Director/Board Member at TELOMIR PHARMACEUTICALS, INC.
Net worth: 273 222 $ as of 2024-03-30
Profile
Talhia T.
Tuck is an Independent Director at Telomir Pharmaceuticals, Inc. She previously worked as an Associate Director-Admissions at Georgetown University from 2016 to 2019.
She also served as an Independent Director at MIRA Pharmaceuticals, Inc. from 2021 to 2024.
Additionally, Talhia held the position of VP-Communications & Investor Relations at Rock Creek Pharmaceuticals, Inc. She completed her undergraduate degree at Harvard University in 2000 and obtained her graduate degree from Harvard Law School in 2010.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-28 | 48,781 ( 0.16% ) | 251 222 $ | 2024-03-30 | |
| 2023-08-02 | 20,000 ( 0.14% ) | 22 000 $ | 2024-03-30 |
Talhia Tuck active positions
| Companies | Position | Start |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director/Board Member | 2022-10-31 |
Former positions of Talhia Tuck
| Companies | Position | End |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director/Board Member | 2024-03-08 |
| Georgetown University | Corporate Officer/Principal | 2018-12-31 |
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | 2014-03-31 |
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Training of Talhia Tuck
| Harvard University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MIRA PHARMACEUTICALS, INC. | Health Technology |
| TELOMIR PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL. | Health Technology |
- Stock Market
- Insiders
- Talhia Tuck